2021
The Use of Aerosolized Medications in Adult Intensive Care Unit Patients: A Prospective, Multicenter, Observational, Cohort Study
Lyu S, Li J, Wu M, He D, Fu T, Ni F, Tan X, Wu G, Pan B, Li L, Wang H, Zeng G, Ni Z, Tan W, Zong Y, Chen L, Liu P, Qin H, He P, Zhang L, An Y, Liang Z, Xie L, Li Y, Zhou M, Li Q, Zhao J, Fang B, Ma Y, Huang R, Guo W, Dong X, Huang X, MO G, Xia J, Xiao K, Zhao H, Kong X, Zhao H, Ma J, Gao P, Yang W, Han F, Dong Y, Ye L, Chen C, Bao Z, Liu Y, Zheng C, Miao L, Yao M, Wang W, Wei S, Li H, Luo F, Liang G, Li J, Zhang C, Dai L, Song L, Wang C, Wang S. The Use of Aerosolized Medications in Adult Intensive Care Unit Patients: A Prospective, Multicenter, Observational, Cohort Study. Journal Of Aerosol Medicine And Pulmonary Drug Delivery 2021, 34: 383-391. PMID: 34129389, DOI: 10.1089/jamp.2021.0004.Peer-Reviewed Original ResearchMeSH KeywordsAdministration, InhalationAdultBronchodilator AgentsCohort StudiesHumansIntensive Care UnitsProspective StudiesConceptsIntensive care unitAerosol therapyAerosolized medicationsCohort studySide effectsShort-acting muscarinic antagonistsCombination of inhaled corticosteroidsChronic obstructive pulmonary disease exacerbationsIntensive care unit patientsSpontaneously breathing patientsAdult intensive care unit patientsAdult ICU patientsChinese ICUsBreathing patientsRespiratory supportMuscarinic antagonistInhaled corticosteroidsAdult patientsClinical outcomesMechanical ventilationDisease exacerbationUnit patientsCare unitConclusion:</i></b>ICU patients
2020
Evaluation of the New American Urological Association Guidelines Risk Classification for Hematuria
Woldu S, Ng C, Loo R, Slezak J, Jacobsen S, Tan W, Kelly J, Lough T, Darling D, van Kessel K, de Jong J, van Criekinge W, Shariat S, Hiar A, Brown S, Boorjian S, Barocas D, Svatek R, Lotan Y. Evaluation of the New American Urological Association Guidelines Risk Classification for Hematuria. Journal Of Urology 2020, 205: 1387-1392. PMID: 33356483, DOI: 10.1097/ju.0000000000001550.Peer-Reviewed Original ResearchConceptsIncidence of bladder cancerBladder cancerHigh-risk groupRisk groupsRisk strataCancer incidenceDegree of hematuriaHigh-risk patientsRisk stratification systemAmerican Urological AssociationEvaluation of patientsMultinational cohort studyRisk-stratified approachBladder cancer incidenceHematuria patientsClinically meaningful categoriesGross hematuriaUrologic evaluationIntermediate riskProspective registryRisk patientsContemporary patientsSmoking historyUrological AssociationHematuriaDelayed blood transfusion is associated with mortality following radical cystectomy
Tan W, Wang Y, Trinh Q, Preston M, Kelly J, Hrouda D, Kibel A, Krasnow R, Liu J, Chung B, Chang S, Mossanen M. Delayed blood transfusion is associated with mortality following radical cystectomy. Scandinavian Journal Of Urology 2020, 54: 290-296. PMID: 32538224, DOI: 10.1080/21681805.2020.1777195.Peer-Reviewed Original ResearchConceptsDelayed blood transfusionEarly blood transfusionBlood transfusionRadical cystectomyBladder cancer treated with radical cystectomyPatients treated with radical cystectomyAssociated with 90-day mortalityIncreased 90-day mortalityTime of blood transfusionPrimary end pointRetrospective cohort studyMultivariate logistic regressionAssociated with mortalityDelayed transfusionMedian ageClinical deteriorationCystectomyHigher CCIOlder patientsTransfusionCohort studyEnd pointsPatient mortalityPatientsIndex admission
2018
Can Renal and Bladder Ultrasound Replace Computerized Tomography Urogram in Patients Investigated for Microscopic Hematuria?
Tan W, Sarpong R, Khetrapal P, Rodney S, Mostafid H, Cresswell J, Hicks J, Rane A, Henderson A, Watson D, Cherian J, Williams N, Brew-Graves C, Feber A, Kelly J, Collaborators D. Can Renal and Bladder Ultrasound Replace Computerized Tomography Urogram in Patients Investigated for Microscopic Hematuria? Journal Of Urology 2018, 200: 973-980. PMID: 29702097, PMCID: PMC6179963, DOI: 10.1016/j.juro.2018.04.065.Peer-Reviewed Original ResearchConceptsUpper tract urothelial cancerComputerized tomography urogramBladder ultrasoundIncidence of bladderUrinary tract cancerMicroscopic hematuriaUrothelial cancerBladder cancerIncidence of upper tract urothelial cancerIncidence of urinary tract cancerRenal calculiPredictive valueUpper tract imagingDetecting bladder cancerNegative predictive valueDetect renal cancerDiagnosed bladder cancerPositive predictive valueSuspected renal calculiHematuria casesMacroscopic hematuriaRenal cancerHematuriaInvestigated patientsCystoscopy
2015
Is Prebiopsy MRI Good Enough to Avoid Prostate Biopsy? A Cohort Study Over a 1-Year Period
Lamb B, Tan W, Rehman A, Nessa A, Cohen D, O'Neil J, Green J, Hines J. Is Prebiopsy MRI Good Enough to Avoid Prostate Biopsy? A Cohort Study Over a 1-Year Period. Clinical Genitourinary Cancer 2015, 13: 512-517. PMID: 26231912, DOI: 10.1016/j.clgc.2015.06.007.Peer-Reviewed Original ResearchConceptsMultiparametric magnetic resonance imagingPrebiopsy multiparametric magnetic resonance imagingNational Comprehensive Cancer NetworkProstate multiparametric magnetic resonance imagingTransrectal ultrasound prostate biopsySignificant prostate cancerTransrectal ultrasound biopsyProstate biopsyTransrectal ultrasoundProstate cancerNational Comprehensive Cancer Network high-riskSensitivity of multiparametric magnetic resonance imagingDetect clinically significant prostate cancerSystematic 12-core prostate biopsyClinically significant prostate cancerMRI scansPredictive valueNegative MRI scansGleason score 8High-risk diseasePositive MRI scansNegative predictive valuePositive predictive valueComprehensive Cancer NetworkRisk of complications